Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Spatial Investigation of Tuberculosis Dynamics and Affecting Factors in Şanlıurfa, Türkiye (2016-2023).

GeoHealth·2025
Same author

Sutureless versus conventional suture renorrhaphy in clampless robotic partial nephrectomy: A single center propensity score matching analysis.

Actas urologicas espanolas·2025
Same author

Evaluation of follow-up colonoscopy in acute colonic diverticulitis for detection of advanced adenoma and colon cancer: a retrospective cohort study.

Hippokratia·2022
Same author

Determining anatomical localisations of cervical oesophagus, hiatal clamp and oesophagogastric junction with oesophagogastroduodenoscopy.

Folia morphologica·2022
Same author

Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine.

European review for medical and pharmacological sciences·2021
Same author

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Clinical and experimental dermatology·2021

Related Experiment Video

Updated: May 16, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Cervical lymphadenitis: tuberculosis or tularaemia?

O Karabay1, S Kilic, S Gurcan

  • 1Department of Infectious Diseases, Sakarya University Medical Faculty, Sakarya, Turkey. drkarabay@yahoo.com

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|December 6, 2012
PubMed
Summary
This summary is machine-generated.

Tuberculosis cervical lymphadenitis (TCL) and oropharyngeal tularaemia (OT) share similar symptoms. This study found tularaemia antibodies in 6.75% of TCL patients in Turkey, suggesting tularaemia testing for suspected TCL cases in endemic areas.

Related Experiment Videos

Last Updated: May 16, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Tuberculosis cervical lymphadenitis (TCL) and oropharyngeal tularaemia (OT) present with overlapping clinical and pathological features.
  • Differentiating these conditions is crucial for accurate diagnosis and treatment, especially in regions where both are endemic.

Purpose of the Study:

  • To determine the frequency of tularaemia antibodies in patients diagnosed with TCL in Turkey.
  • To assess the diagnostic value of tularaemia serology in TCL patients.

Main Methods:

  • A cross-sectional study involving 1170 TCL patients and 596 healthy controls from Turkey (2008-2011).
  • Sera were tested for Francisella tularensis antibodies using microagglutination technique (MAT).
  • Brucella antibodies were tested in tularaemia-seropositive sera to evaluate cross-reactivity.

Main Results:

  • Tularaemia antibodies (MAT titre ≥1:80) were detected in 6.75% of TCL patients versus 0.33% of controls (p < 0.01).
  • Considering any antibody titre, 8.2% of TCL patients and 0.67% of controls were seropositive (p < 0.001).
  • This study is the first to report a significant prevalence of positive tularaemia serology in diagnosed TCL cases.

Conclusions:

  • Tularaemia serology should be considered in the differential diagnosis of suspected TCL, particularly in tularaemia-endemic regions.
  • The findings highlight the importance of investigating tularaemia in patients presenting with symptoms consistent with TCL.